October 25th 2023 Business Meeting, Atlanta - Drug Content Analysis Project Group

Meeting recording:

Zoom Details in Meeting Invite

https://snomed.zoom.us/j/89353278760
Password: 113582

Join from PC, Mac, Linux, iOS or Android

Attendees

In person:

@Monica Harry@Nicola Ingram@Hanne Fjeldstad Johansen @Ian Spiers

@Krista Lilly @Michael Jones (Unlicensed) @Megan Berry (Unlicensed) @Theresa Barry @Former user (Deleted) @Rutt Lindström @Justin Stout (Unlicensed) @Former user (Deleted) @Guillermo Reynoso @Alejandro Lopez Osornio @Stuart Abbott (Unlicensed) @Rob Hausam @Stan Huff

Online @Julie James (BW) (Unlicensed)

@Emma Melhuish (Unlicensed) @David Mitchell (Unlicensed) @Marta Pavón Garrido @Shane Byrnes @ines otegui

Wednesday 25th October at 13:30-15:00 EDT Atlanta local time.

This is 17:30-19:00 UTC for those attending virtually.

Discussion items

	Topic	Discussion Points	Speaker	Notes from Call

	Topic	Discussion Points	Speaker	Notes from Call
1		Reminder to record call!	Monica Harry	MEETING RECORDINGS are stored here: https://drive.google.com/drive/folders/1_tIy8TQapc6cqCwqpvNK6RwfBIhYqzD4
2		Welcome and introductions	Monica Harry
3	Current topic	Current topic in review Anti-diabetic drugs: pre-filled cartridges Decision All agreed concentration strength - see presentation for discussion points covered during this interesting item.	Julie James
4	International units and SNOMED CT clinical drugs	Feedback on international units discussion from Editorial Advisory Group Decision All agreed with use of 'units' instead of 'international units'	Monica Harry Nicki Ingram
5	DCAP PROJECT DISCUSSION	Anti-diabetic drugs - review underway. Email Hanne to share worksheet and take part. The next area of work is proposed to be anti-epileptic drugs. *The future and expanding new international drugs content. DCAP? How to generate more DCAP member country involvement in review of concepts? Proposals: 1. No longer require Reviewers to provide evidence for Clinical Drug. Therefore no need to research to locate Summary of Product Characteristics (SPC, SmPC). 2. Only requirement would be to say if countries have the Clinical Drug in their content. Therefore could be a speedy automated check for duplicates. How to involve more member countries in participating in providing initial lists of drugs for DCAP review, with authoritative references, for import to International edition? Discussion	Hanne Fjeldstad Johansen Julie James
6	AOB		All
7	Upcoming Calls and Events	Next call: